Lyell Immunopharma LYEL
NASDAQ LYEL
$9.26 -0.15 (-1.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lyell Immunopharma (LYEL) Cash from Investing Activities (2020 - 2026)

Updated

Lyell Immunopharma's Cash from Investing Activities was $15.62 million in Q2 2026, up 23.5% from $12.65 million a year earlier but down 10.1% from the prior quarter.

Analysis

Lyell Immunopharma (LYEL) Cash from Investing Activities (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Lyell Immunopharma's Cash from Investing Activities was $4.98 million through Jun 30, 2026, down 96.4% year-over-year; for FY2025, it was $54.1 million, down 55.8% from FY2024.

  • In earlier years, Cash from Investing Activities was $122.42 million in FY2024 (-33.5%), $184.05 million in FY2023, -$11.54 million in FY2022 and -$121.57 million in FY2021.
  • Quarterly Cash from Investing Activities has moved between -$144.91 million (Q3 2021) and $152.91 million (Q2 2023) over five years.
  • Compared with a year earlier, Cash from Investing Activities was higher in three of the last six quarters, with growth averaging 11.5%.
  • The best year-over-year quarter for Cash from Investing Activities over five years was Q2 2023 (growth of 511.2%); the worst was Q3 2024 (a decline of 98.1%).
  • Per Business Quant data, LYEL's Cash from Investing Activities in the three quarters before Q2 2026 was $17.38 million (Q1 2026), -$31.37 million (Q4 2025) and $3.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Lyell Immunopharma 216.66 Mn 216.66 Mn - 15.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.62 Mn
Mar 31, 2026 17.38 Mn
Dec 31, 2025 -31.37 Mn
Sep 30, 2025 3.35 Mn
Jun 30, 2025 12.65 Mn
Mar 31, 2025 69.47 Mn
Dec 31, 2024 53.51 Mn
Sep 30, 2024 1.92 Mn
Jun 30, 2024 45.01 Mn
Mar 31, 2024 21.99 Mn
Dec 31, 2023 -100.69 Mn
Sep 30, 2023 99.67 Mn
Jun 30, 2023 152.91 Mn
Mar 31, 2023 32.15 Mn
Dec 31, 2022 46.65 Mn
Sep 30, 2022 -57.09 Mn
Jun 30, 2022 25.02 Mn
Mar 31, 2022 -26.12 Mn
Dec 31, 2021 -73.86 Mn
Sep 30, 2021 -144.91 Mn
API Access

Lyell Immunopharma Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=LYEL&period=max&api_key=YOUR_API_KEY